Breast cancer resistance protein: molecular target for anticancer drug resistance and pharmacokinetics/pharmacodynamics (Q34444082)

2 August 2017

1 reference

title

Breast cancer resistance protein: molecular target for anticancer drug resistance and pharmacokinetics/pharmacodynamics (English)

1 reference

2 August 2017

1 reference

1 reference

1 reference

1 reference

Yoshikazu Sugimoto

1

1 reference

2 August 2017

Satomi Tsukahara

series ordinal

2

1 reference

2 August 2017

Etsuko Ishikawa

series ordinal

3

1 reference

2 August 2017

Junko Mitsuhashi

series ordinal

4

1 reference

2 August 2017

publication date

1 August 2005

1 reference

2 August 2017

1 reference

2 August 2017

volume

96

1 reference

2 August 2017

issue

8

1 reference

2 August 2017

page(s)

457-465

1 reference

Internal duplication and homology with bacterial transport proteins in the mdr1 (P-glycoprotein) gene from multidrug-resistant human cells.

2 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111/J.1349-7006.2005.00081.X

A multidrug resistance transporter from human MCF-7 breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1349-7006.2005.00081.X

Breast cancer resistance protein directly confers SN-38 resistance of lung cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1349-7006.2005.00081.X

Dominant-negative inhibition of breast cancer resistance protein as drug efflux pump through the inhibition of S-S dependent homodimerization

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1349-7006.2005.00081.X

Estrone and 17beta-estradiol reverse breast cancer resistance protein-mediated multidrug resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1349-7006.2005.00081.X

A new multidrug resistance protein at the blood-brain barrier

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1349-7006.2005.00081.X

The ABC transporter Bcrp1/ABCG2 is expressed in a wide variety of stem cells and is a molecular determinant of the side-population phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1349-7006.2005.00081.X

Expression and activity of breast cancer resistance protein (BCRP) in de novo and relapsed acute myeloid leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1349-7006.2005.00081.X

Increased expression of the breast cancer resistance protein (BCRP) in relapsed or refractory acute myeloid leukemia (AML)

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1349-7006.2005.00081.X

BCRP gene expression is associated with a poor response to remission induction therapy in childhood acute myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1349-7006.2005.00081.X

High-affinity interaction of tyrosine kinase inhibitors with the ABCG2 multidrug transporter

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1349-7006.2005.00081.X

Imatinib mesylate (STI571) is a substrate for the breast cancer resistance protein (BCRP)/ABCG2 drug pump

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1349-7006.2005.00081.X

The breast cancer resistance protein protects against a major chlorophyll-derived dietary phototoxin and protoporphyria.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1349-7006.2005.00081.X

The breast cancer resistance protein BCRP (ABCG2) concentrates drugs and carcinogenic xenotoxins into milk.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1349-7006.2005.00081.X

Single amino acid substitutions in the transmembrane domains of breast cancer resistance protein (BCRP) alter cross resistance patterns in transfectants.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1349-7006.2005.00081.X

Folate deprivation results in the loss of breast cancer resistance protein (BCRP/ABCG2) expression. A role for BCRP in cellular folate homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1349-7006.2005.00081.X

Breast cancer resistance protein exports sulfated estrogens but not free estrogens

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1349-7006.2005.00081.X

Sex-dependent expression and activity of the ATP-binding cassette transporter breast cancer resistance protein (BCRP/ABCG2) in liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1349-7006.2005.00081.X

Functional analysis of SNPs variants of BCRP/ABCG2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1349-7006.2005.00081.X

Functional assessment of ABCG2 (BCRP) gene polymorphisms to protein expression in human placenta.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1349-7006.2005.00081.X

Natural allelic variants of breast cancer resistance protein (BCRP) and their relationship to BCRP expression in human intestine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1349-7006.2005.00081.X

Diflomotecan pharmacokinetics in relation to ABCG2 421C>A genotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1349-7006.2005.00081.X

Increased oral bioavailability of topotecan in combination with the breast cancer resistance protein and P-glycoprotein inhibitor GF120918.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1349-7006.2005.00081.X

10.1111/J.1349-7006.2005.00081.X

21 January 2018

Identifiers

DOI

1 reference

2 August 2017

1 reference